Trademark: 98687535
Word
Status
Pending
Status Code
630
Status Date
Wednesday, August 7, 2024
Serial Number
98687535
Filing Date
Wednesday, August 7, 2024

Trademark Owner History

Classifications
5 Pharmaceutical preparations for genetic therapies to treat genetically driven disorders in the fields of neurology, gastroenterology, metabolism, immunology, dyslipidaemia, the musculoskeletal system, oncology, and diseases of the retina, liver, heart, lung, bone marrow, brain, muscle, immune system, and kidney; Reagents, nucleic acids, and nucleotides for medical and veterinary purposes; all of the foregoing excluding pharmaceuticals for the treatment of xerostomia.
1 Reagents, nucleic acids, and nucleotides for scientific and research use in the fields of clinical research, drug development, agriculture and genetics research; reagent kits comprised of reagents and chemical preparations for scientific research purposes; samples of nucleotide sequence variants and modified nucleotide sequences for use in the fields of scientific research, clinical research, and scientific diagnostics research.
42 Scientific and laboratory research services in the fields of gene, genome and cellular editing, modification, engineering and regulation for use in developing human and veterinary pharmaceutical and biological preparations; custom design and development of engineered cell lines for others for use in scientific research, and drug discovery and development.
The mark consists of a double helix circular design.
Color is not claimed as a feature of the mark.

Trademark Events
Aug 7, 2024
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24